Zantac Uterine Cancer

Zantac is currently receiving a good deal of media attention for the unfortunate reason that it’s been associated with a probable carcinogen (cancer-causing agent) that is considered extremely dangerous. The Food and Drug Administration recently withdrew Zantac and other ranitidine products from the market because of its connection with the contaminate NDMA (N-Nitrosodimethylamine). Multiple national and international health agencies identify NDMA as a probable carcinogen, and uterine cancer is one type that’s been associated.

The Discovery

In the spring of 2019, a small online pharmacy called Valisure was conducting routine drug testing in accordance with its commitment to assuring quality and safety for its customers and, in the process, discovered NDMA across lots of Zantac and other ranitidine products. With the announcement, some manufacturers of the drug and some large drugstore chains shutdown sales from their end. In April of 2020, the FDA followed suit. The extreme nature of these actions speaks to the seriousness of the associated risk.

Your Damages

If you contracted uterine cancer as a result of your Zantac usage, your damages are likely to be considerable, including:

• Immense medical expenses related to ongoing treatment and care
• Lost hours and wages on the job
• The pain and suffering associated with enduring a painful disease and treatment process as a result of purchasing and taking a drug intended to help restore your health

Your Case Is Important, and an Experienced Drug Injury Lawyer Can Help

If you took Zantac and have been diagnosed with uterine cancer, you don’t have to face the future alone. A dedicated drug injury lawyer will build your strongest case in support of your rights and your rightful compensation.